DSGN
Design Therapeutics, Inc. Common Stock ·
Design Therapeutics, Inc. Common Stock (DSGN) is held by 1 tracked hedge fund(s). Largest tracked holder: BAKER BROS. ADVISORS LP.
Insider trades open-market, past year
No reported open-market insider trades in the past year.
Open-market Form 4 transactions (grants & option exercises excluded). Live from SEC filings.
Congress buys & sells disclosed trades
No disclosed Congressional trades on this stock.
Price chart
Financials
Symbol info, price chart & financials are live from TradingView (real data — no processing).
📊
Deep Dive — full fundamental analysis
An analyst-grade breakdown of DSGN: the bull & bear thesis, valuation model, segment detail and risks — written from SEC filings.
- Bull & bear case, with conviction score
- Owner-earnings & valuation model
- Segment & geographic revenue breakdown
- Key risks & what would break the thesis
- Peer comparison (vs sector)
🔒 Unlock with WealthFile Pro
⚡
Daily Moves — what's moving DSGN today
A daily, plain-English read on the day's price action and the smart-money & news catalysts behind it.
- Today's price drivers, explained
- Smart-money flow alerts (fund / insider / Congress)
- News & SEC-filing catalysts
- Unusual options activity
🔒 Unlock with WealthFile Pro
Related ▾
FAQ ▾
Which hedge funds hold DSGN?
Tracked holders include: BAKER BROS. ADVISORS LP.
How much smart money owns DSGN?
1 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading DSGN?
No tracked Congressional trades in DSGN on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.